ArticleHepatology (Baltimore, Md.)2014
Eradication of hepatitis C infection: the importance of targeting people who inject drugs.
Article in Hepatology (Baltimore, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses.PloS one · 2015Pooled it
- Regional epidemiological study of hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners.BMC public health · 2025Article
- Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs.Healthcare (Basel, Switzerland) · 2024Article
- Meet-Test-Treat for HCV management: patients' and clinicians' preferences in hospital and drug addiction services in Italy.BMC infectious diseases · 2022Article
- "Like a pickle that's been unpickled": Emotional, identity and behavioural transformations throughout hepatitis C treatment.PloS one · 2022Article
- Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020.Preventing chronic disease · 2021Article
- Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs.Scientific reports · 2021Article
- Excitable models: Projections, targets, and the making of futures without disease.Sociology of health & illness · 2021Article
- A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.The Journal of infectious diseases · 2020Article
- Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics.Clinical liver disease · 2020Review
- Optimization of hepatitis C virus screening strategies by birth cohort in Italy.Liver international : official journal of the International Association for the Study of the Liver · 2020Article
- The Elimination of Hepatitis C as a Public Health Threat.Cold Spring Harbor perspectives in medicine · 2020Review
- Article
- Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives.Open forum infectious diseases · 2019Article
- Article
- Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs.Harm reduction journal · 2019Article
- A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015.Journal of the International AIDS Society · 2019Article
- Injection drug network characteristics as a predictor of injection behaviour.Epidemiology and infection · 2019Article
- Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?Liver international : official journal of the International Association for the Study of the Liver · 2018Article
- Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice.Infectious disease clinics of North America · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.